TCL Archive NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials. May 4, 2001
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive Aetna No Longer To Cover HDC/BMT For Breast Cancer Outside Of Clinical Trials. February 25, 2000